Key facts
- This page summarizes Scott Centea's Form 4 filing for ANGIODYNAMICS INC (ANGO).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 25 Jul 2023, 19:06.
Scott Centea - 20 Jul 2023 Form 4 Insider Report for ANGIODYNAMICS INC (ANGO)
- Reporting relationship
- SVP/GM, VIT
- Issuer ticker
- ANGO
- Reported as of
- 20 Jul 2023
- Net transaction value
- -$5,116
- SEC form
- 4
- Accepted by SEC
- 25 Jul 2023, 19:06:59 UTC
- Prior SEC filing
- 21 Jul 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Stephen A. Trowbridge, Attorney in Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Scott Centea filed Form 4 for ANGIODYNAMICS INC (ANGO) on 25 Jul 2023.
Change
- Previous filing in this sequence was filed on 21 Jul 2023.
- Current net transaction value: -$5,116.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ANGO
transaction
Common Stock
Tax liability
- Transaction value
- $2,910
- Shares
- -333
- Change %
- -0.57%
- Price
- $8.74
- Shares after
- 58,383
- Date
- 20 Jul 2023
- Ownership
- Direct
- Footnotes
- F1
ANGO
transaction
Common Stock
Tax liability
- Transaction value
- $2,206
- Shares
- -255
- Change %
- -0.44%
- Price
- $8.65
- Shares after
- 58,128
- Date
- 21 Jul 2023
- Ownership
- Direct
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The exempt disposition of 333 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022.
Footnote F2
The exempt disposition of 255 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 21, 2021.